BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3021693)

  • 1. Influence of WR 2721 on radiation response of canine soft tissue sarcomas.
    McChesney SL; Gillette EL; Dewhirst MW; Withrow SJ
    Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):1957-63. PubMed ID: 3021693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation-induced osteosarcoma in dogs after external beam or intraoperative radiation therapy.
    Gillette SM; Gillette EL; Powers BE; Withrow SJ
    Cancer Res; 1990 Jan; 50(1):54-7. PubMed ID: 2403417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation as a therapeutic modality in sarcomas of the soft tissue.
    Suit H; Spiro I
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):733-46. PubMed ID: 7490238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthovoltage radiation and weekly low dose of doxorubicin for the treatment of incompletely excised soft-tissue sarcomas in 39 dogs.
    Simon D; Ruslander DM; Rassnick KM; Wood CA; Frimberger AE; Cotter SM; King NW; Moore AS
    Vet Rec; 2007 Mar; 160(10):321-6. PubMed ID: 17351172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioprotection of normal tissues against gamma rays and cyclotron neutrons with WR-2721: LD50 studies and 35S-WR-2721 biodistribution.
    Rasey JS; Nelson NJ; Mahler P; Anderson K; Krohn KA; Menard T
    Radiat Res; 1984 Mar; 97(3):598-607. PubMed ID: 6328565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mouse lung by WR-2721 after fractionated doses of irradiation.
    Travis EL; De Luca AM
    Int J Radiat Oncol Biol Phys; 1985 Mar; 11(3):521-6. PubMed ID: 2982773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of mouse bone marrow by WR-2721 after fractionated irradiation.
    Travis EL; Fang MZ; Basic I
    Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):377-82. PubMed ID: 2841264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study.
    Gillette SM; Dewhirst MW; Gillette EL; Thrall DE; Page RL; Powers BE; Withrow SJ; Rosner G; Wong C; Sim DA
    Int J Hyperthermia; 1992; 8(3):309-20. PubMed ID: 1607736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic response of irradiated T-lymphocytes. An epidemiologic study in canine radiotherapy patients.
    Stankeová S; Crompton NE; Blattmann H; Theiler P; Emery GC; Roos M; Kaser-Hotz B
    Strahlenther Onkol; 2003 Nov; 179(11):779-86. PubMed ID: 14605749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection by WR-2721 of human bone marrow function following irradiation.
    Constine LS; Zagars G; Rubin P; Kligerman M
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1505-8. PubMed ID: 2428794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of X ray dose levels on normal tissue radioprotection by WR-2721.
    Rojas A; Denekamp J
    Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2351-6. PubMed ID: 6096318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the outlook grey for WR-2721 as a clinical radioprotector?
    Denekamp J; Stewart FA; Rojas A
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1247-9. PubMed ID: 6307942
    [No Abstract]   [Full Text] [Related]  

  • 13. Soft tissue sarcomas in dogs.
    Mayer MN; LaRue SM
    Can Vet J; 2005 Nov; 46(11):1048, 1050, 1052. PubMed ID: 16363335
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of calcitonin gene related peptide vs sodium nitroprusside to increase temperature in spontaneous canine tumours during local hyperthermia.
    Poulson JM; Vujaskovic Z; Gaskin AA; Larue SM; Meyer RE; Prescott DM; Samulski TV; Thrall DE; Dewhirst MW
    Int J Hyperthermia; 2004 Aug; 20(5):477-89. PubMed ID: 15277021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amifostine: is there evidence of tumor protection?
    Koukourakis MI
    Semin Oncol; 2003 Dec; 30(6 Suppl 18):18-30. PubMed ID: 14727237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiotherapy for canine soft tissue sarcoma.
    Forrest LJ; Chun R; Adams WM; Cooley AJ; Vail DM
    J Vet Intern Med; 2000; 14(6):578-82. PubMed ID: 11110377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
    Murray D; Altschuler EM; Hunter N; Milas L
    Radiat Res; 1989 Nov; 120(2):339-51. PubMed ID: 2559423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of bone marrow by WR-2721 after fractionated irradiation.
    Coia LR; Brown DQ
    Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):908-9. PubMed ID: 2550401
    [No Abstract]   [Full Text] [Related]  

  • 19. Fractionation studies with WR-2721: normal tissues and tumour.
    Rojas A; Stewart FA; Soranson JA; Smith KA; Denekamp J
    Radiother Oncol; 1986 May; 6(1):51-60. PubMed ID: 3012656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma.
    Kung MBJ; Poirier VJ; Dennis MM; Vail DM; Straw RC
    Vet Comp Oncol; 2016 Dec; 14(4):e135-e145. PubMed ID: 25393921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.